Development asset linked to Lakewood-Amedex Biotherapeutics in public FDA and regional records.
pharma · Chronic Diabetic Foot Ulcers · Diabetic Foot Infection · LABT
Lakewood-Amedex Biotherapeutics
Lakewood-Amedex Biotherapeutics drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Company details
- Status
- Public
- HQ
- University Park, USA
- Employees
- 8
- Programs
- 4
- Drugs
- 1
- Patents
- 18
Lakewood-Amedex Biotherapeutics pipeline
Portfolio lens on 1 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Lakewood-Amedex Biotherapeutics drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.